Challenges for omics technologies in the implementation of personalized medicine

Research output: Contribution to journalEditorialOtherpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)229-231
Number of pages3
JournalExpert Review of Precision Medicine and Drug Development
Volume3
Issue number4
DOIs
Publication statusPublished - 4 Jul 2018

Keywords

  • P4 (predictive, preventive, personalized, participatory) medicine
  • precision/personalized medicine
  • proteogenomics
  • proteomics
  • The omics pipeline

Cite this

@article{8e8fd91fd59c4fcb9a8560399c1145a2,
title = "Challenges for omics technologies in the implementation of personalized medicine",
keywords = "P4 (predictive, preventive, personalized, participatory) medicine, precision/personalized medicine, proteogenomics, proteomics, The omics pipeline",
author = "Nice, {Edouard C.}",
year = "2018",
month = "7",
day = "4",
doi = "10.1080/23808993.2018.1505429",
language = "English",
volume = "3",
pages = "229--231",
journal = "Expert Review of Precision Medicine and Drug Development",
issn = "2380-8993",
publisher = "Taylor & Francis",
number = "4",

}

Challenges for omics technologies in the implementation of personalized medicine. / Nice, Edouard C.

In: Expert Review of Precision Medicine and Drug Development, Vol. 3, No. 4, 04.07.2018, p. 229-231.

Research output: Contribution to journalEditorialOtherpeer-review

TY - JOUR

T1 - Challenges for omics technologies in the implementation of personalized medicine

AU - Nice, Edouard C.

PY - 2018/7/4

Y1 - 2018/7/4

KW - P4 (predictive, preventive, personalized, participatory) medicine

KW - precision/personalized medicine

KW - proteogenomics

KW - proteomics

KW - The omics pipeline

UR - http://www.scopus.com/inward/record.url?scp=85051079239&partnerID=8YFLogxK

U2 - 10.1080/23808993.2018.1505429

DO - 10.1080/23808993.2018.1505429

M3 - Editorial

VL - 3

SP - 229

EP - 231

JO - Expert Review of Precision Medicine and Drug Development

JF - Expert Review of Precision Medicine and Drug Development

SN - 2380-8993

IS - 4

ER -